A Caucasian boy with a de novo complex chromosome rearrangement owing to six chromosome breaks was small for gestation with microcephaly, complex heart defect, hypotonia, left auricular pit, simian creases, and ankyloblepharon filiforme adnatum. The rearrangement included two translocations, t(15;21) (q22;q22) and t(3;11)(
filiforme adnatum. The rearrangement included two translocations, t(15;21) (q22;q22) and t(3;11)(q21;qll), with the derivative 3 showing in addition pericentric inversion (pllqll) and interstitial deletion (qllq2 1). Based on parental satellite polymorphisms of chromosomes 15 and 21, the paternal gamete appeared to be the source of the chromosome ref a , W 46 cm, and head circumference 30 cm at 39 weeks' gestation) were noted. He was the product of the first pregnancy of a healthy, non-consanguineous, 20 year old mother and 22 year old father. The pregnancy was uneventful. However, the mother had a history of chronic cystitis with antibiotic treatment and dilatation of the urethra; this was months before the conception. She a vague yet plausible pathogenetic mechanism for the CCR. As a clinical manifestation AFA has not been reported in group II CCR patients. However, it is a part of the normal fetal development with separation of eyelids before 32 weeks' gestation. As in the reported patient, a failure of eyelid separation is unlikely to indicate a specificity for a particular breakpoint. In addition, the developmental timetable for the fusion/separation of the eyelids is quite lengthy, extending between the 8th and 32nd weeks. Thus, to elaborate on the disruption of eyelid fusion/separation as a sign of dysmorphogenesis would be highly speculative. 6 On the other hand, just as for the other major and minor phenotypic aberrations, the numerous breakpoints must have played a role, either dissecting functional genes or displacing modifier genes leading to the disruption of the chronogenetic table and lack of eyelid separation at 39 weeks' gestation.
In regard to CCRs and their pathogenesis, knowledge is still in the descriptive, morphological stage and currently only a few subspecialists know that congenital CCR is a biological phenomenon in humans which, on occasion, is compatible with zygote survival and postnatal life despite phenotypic aberrations. Increased awareness of CCR is necessary and will contribute to the understanding of these patients.
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